MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics

B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz (Tübingen, Germany)

Meeting: 2017 International Congress

Abstract Number: 847

Keywords: Prion diseases. See Transmissible spongiform encephalopathies

Session Information

Date: Wednesday, June 7, 2017

Session Title: Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To determine whether levels of neurofilament light chain (NFL) in cerebrospinal fluid (CSF) are useful to discriminate between patients with prion disease (PrD) and patients with a diagnosis mimicking Prion disease (PrMim).

Background: NFL is a structural protein of the neural cytoskeleton, essential for axonal growth, transport and signalling. Higher levels of CSF-NFL reflect axonal degeneration. Recently, NFL was shown to also be elevated in Creutzfeld-Jacobs-Disease (CJD) compared to controls and Alzheimer’s disease (AD) patients [1]. To our knowledge no data is available comparing NFL levels of patients with PrD and PrMim. 

Methods: Thirty-one patients with Prion disease as a potential differential diagnosis were evaluated in our hospital between 2010 and 2016. In the diagnostic process CSF was collected using standard procedures. NFL was measured using electrochemiluminiscence immunoessay (NF-light). Total-Tau (t-Tau) was measured using commercially available ELISA kits (Innogenetics NV, Ghent, Belgium).

Results: 10/31 patients fulfilled the diagnosis of Prion disease according to consensus criteria (age 65.5y ± 8.4, male/female=8/2) while 21/31 (66.3y ± 12.3, 8/13) received a different diagnosis after diagnostic workup, including autoimmune encephalopathy, rapidly progressive AD, status epilepticus and frontotemporal dementia. There was no significant difference in CSF levels of NFL between the PrD group (mean 10,654pg/ml, range 3855- 44,9930pg/ml, SD=12,201pg/ml) and the PrMim group (10,781pg/ml, 608-50,000pg/ml, SD=12,347pg/ml), (Kruskal-Wallis, p=0.17). (Figure 1) NFL alone was not useful to discriminate between PrD and PrMim (AUC=0.48), as opposed to CSF t-Tau (PrD: mean 2554 pg/ml, PrMim: mean 1311pg/ml, Kruskal-Wallis, p=0.009, AUC=0.88). A combination of NFL and t-Tau levels did not improve discrimination (AUC= 0.87).

Conclusions: CSF levels of NFL are elevated in patients with PrD. However, there are no significant differences in NFL levels between patients with PrD and PrMim. In contrast to CSF levels of t-Tau, NFL is not useful to discriminate between patients with PrD and patients with PrMim. A combination of NFL and t-Tau did not improve diagnostic accuracy when compared to t-Tau alone. Increased levels of CSF in NFL appear to reflect acuity of neurodegeneration rather than a specific pathophysiological process in PrD.

References: [1] Steinacker P, Blennow K, Halbgebauer S, Shi S, Ruf V, Oeckl P, Giese A, Kuhle J, Slivarichova D, Zetterberg H, Otto M. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease. Sci Rep. 2016 Dec 8;6:38737.

To cite this abstract in AMA style:

B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz. Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/neurofilament-light-chain-levels-in-cerebrospinal-fluid-do-not-discriminate-between-patients-with-prion-disease-and-mimics/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurofilament-light-chain-levels-in-cerebrospinal-fluid-do-not-discriminate-between-patients-with-prion-disease-and-mimics/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley